Physician profile
Kwan J Park
NPI 1265790364
$82,208.84
in general payments reported to CMS, 2019-2025
20 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,300 · 2020: $3,406 · 2021: $6,708 · 2022: $2,384 · 2023: $19K · 2024: $7,278 · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $40K · Consulting Fee: $15K · Travel and Lodging: $6,294 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Food and Beverage: $2,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $39,846.78 |
| Consulting Fee | $14,500.00 |
| Travel and Lodging | $6,294.07 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Food and Beverage | $2,770.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $66,771.23 | 2019-2025 | Avenir, Arcos, G7 |
| Stryker Corporation | $4,309.27 | 2019-2023 | Mako |
| Smith+Nephew, INC. | $4,195.38 | 2019-2025 | Real Intelligence, Pico 14 |
| Synthes Gmbh | $3,644.75 | 2023-2024 | |
| Microport Orthopedics INC | $1,580.15 | 2019-2020 | |
| Medacta USA, INC. | $489.85 | 2024 | |
| Pacira Therapeutics, INC. | $328.25 | 2019-2021 | |
| Davol INC. | $145.21 | 2021 | |
| Engage Uni, LLC | $114.00 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $102.71 | 2021 | |
| Depuy Synthes Sales INC. | $96.28 | 2020-2022 | |
| Medinc of Texas | $92.30 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $84.49 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $52.29 | 2023 | Exparel, Zilretta, Iovera |
| Sanara Medtech INC. | $50.20 | 2025 | Celleraterx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $47.89 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $35.33 | 2025 | Zynrelef |
| Molnlycke Health Care US, LLC | $31.03 | 2025 | Avance |
| Horizon Therapeutics Plc | $26.55 | 2020-2021 | |
| Kci USA, INC. | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kwan Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.